Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CTLA4 antibody

This Mouse Monoclonal antibody specifically detects CTLA4 in ELISA and in vivo. It exhibits reactivity toward Human.
Catalog No. ABIN7543361
$624.00
Plus shipping costs $50.00
200 μg
Shipping to: United States
Delivery in 7 to 13 Business Days

Quick Overview for Recombinant CTLA4 antibody (ABIN7543361)

Target

See all CTLA4 Antibodies
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Antibody Type

Recombinant Antibody

Reactivity

  • 171
  • 105
  • 51
  • 14
  • 10
Human

Host

  • 94
  • 93
  • 22
  • 19
  • 7
  • 2
  • 1
  • 1
  • 1
Mouse

Clonality

  • 168
  • 68
  • 3
Monoclonal

Conjugate

  • 114
  • 20
  • 19
  • 18
  • 13
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CTLA4 antibody is un-conjugated

Application

  • 94
  • 82
  • 65
  • 41
  • 30
  • 29
  • 26
  • 13
  • 10
  • 7
  • 7
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
ELISA, In vivo Studies (in vivo)

Clone

5E3
  • Purpose

    Anti-CTLA-4 [5E3], Mouse IgG1, kappa

    Specificity

    The antibody is specific for CTLA-4. CTLA-4 is a protein receptor that functions as an immune checkpoint and downregulates immune responses.

    Characteristics

    Original Species of Ab: Mouse

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogen

    The original antibody was generated by immunizing BALB/c mice with CTLA-4 protein.

    Isotype

    IgG1 kappa
  • Application Notes

    The specificity of the antibody was confirmed by ELISA analysis. The kinetic parameters of human CTLA-4 protein binding to the antibody were measured and they resulted to be at the sub-nm level. The antitumor activity of the humanized antibody was demonstrated in vivo in animal models. It was proved that the antibody inhibited the tumor in a dose-dependent manner. Mouse PD-1 antibody was combined with the antibody and used to evaluate the toxicity to mice, these experiments compared with the use of Ipilimumab in combination with PD-1 antibody. Results showed that after 5E3 antibody was used in combination with PD-1 antibody, the immunity to the body and the toxicity of heart, liver and lung are significantly lower than the toxicity of Ipilimumab in combination with PD-1 antibody (CN110343180).

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Alternative Name

    CTLA-4

    Background

    Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CD152

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!